COGT Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline BeyondSpring BYSI Q1 2026 Earnings Narrowing Loss and No Revenue as ClinicalStage Biotech Advances Pipeline WERN Q1 2026 Earnings Earnings Beat with Positive Surprise Amid Weak Demand KMPR Q1 2026 Earnings EPS Falls Short of Estimates as Underwriting Challenges Persist ADSK Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower Despite Strong Quarter TRTX Q1 2026 Earnings EPS Slightly Below Estimates Stock Edges Higher